Apgar is a clinical utility for physicians and nurses to calculate newborn health scores based on five standardized factors.
The App DNA
What makes this app unique?
The tool removes the cognitive load of manual scoring during high-pressure post-delivery moments, though current UI defects prevent its use in practice.
For Physicians, nurses, and healthcare professionals requiring a rapid, standardized tool for newborn health assessment.
What does it look like?
Key features
Interactive tool to calculate newborn health scores based on five clinical factors.
Provides standardized interpretation of scores for routine care or critical intervention.
How much does it cost?
The app operates as a free, ad-free utility with no visible monetization or subscription gates.
Velocity
Dormant developmentperformanceopaqueShow more...
Development momentum is classified as zombie due to the extreme disparity in platform support and the lack of meaningful feature updates. While the latest release updated the Android SDK, the iOS version has not seen an update in 1,948 days. The current cadence is insufficient to suggest an active product roadmap, as the recent activity is limited to minor technical maintenance rather than user-facing improvements.
Who built it?
ViralMD
4 apps tracked · Medical
Naula: Your IVF Simplified
Ovulation Calculator App
Due Date Calculator: FertilityUser Sentiment
What do users think recently?
The recent review mood reads frustrated. Users appreciate specialized medical utility provides value for pediatric and anesthesia physicians in clinical environments.
How are ratings & reviews evolving?
What users say, by theme
- Specialized medical utility provides value for pediatric and anesthesia physicians in clinical environments
- Obstructive UI banners block access to critical medical data fields during active patient assessment
3 of 3 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for Apgar
How's the Medical market?
Apgar functions as a niche medical utility with no active monetization. The lack of updates since 2021 on iOS and persistent UI blocking on Android indicate a stagnant market position that fails to meet basic clinical reliability standards.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Apgar
Where is it heading?
The clinical utility market is consolidating around stable, frequently updated tools that guarantee reliability during patient care. Apgar's failure to address basic UI regressions leaves it exposed, and the lack of a clear maintenance roadmap suggests it will continue to lose relevance among medical professionals.
- Persistent UI banners blocking data entry fields prevent clinical use, which erodes professional trust in the tool's reliability.
- The multi-year update gap on iOS suggests the developer has abandoned the platform, leaving the tool vulnerable to OS-level deprecation.
The SWOT
- Standardized clinical scoring logic provides immediate value for pediatric practitioners
- Mobile-first, bug-free clinical assessment tool could capture the niche pediatric market underserved by stagnant utilities
Next best moves
Rebuild UI layout to remove banner obstructions because they block critical data entry fields → restore clinical utility
The counter-intuitive read
The lack of monetization is a liability, not a strength: without revenue…
Read the full takeBottom line
The current UI obstruction invalidates the app's core clinical utility, and a pivot to prioritize interface stability over technical debt would unlock the tool's value for pediatric practitioners.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing, source
Report last updated